Focal adhesion kinase (FAK) regulates numerous cellular functions and is critical for processes ranging from embryo development to cancer progression. Although autophosphorylation on Tyr-397 appears required for FAK functions in vitro, its role in vivo has not been established. We addressed this question using a mutant mouse (fak ∆ ) deleted of exon 15, which encodes Tyr-397. The resulting mutant protein FAK∆ is an active kinase expressed at normal levels. Our results demonstrate that the requirement for FAK autophosphorylation varies during development. FAK ∆/∆ embryos developed normally up to E12.5, contrasting with the lethality at E8.5 of FAKnull embryos. Thus, autophosphorylation on Tyr-397 is not required for FAK to achieve its functions until late mid-gestation. However, FAK ∆/∆ embryos displayed hemorragies, oedema, delayed artery formation, vascular remodelling defects, multiple organs abnormalities, and overall developmental retardation at E13.5-14.5, and died thereafter demonstrating that FAK autophosphorylation is also necessary for normal development. Fibroblasts derived from mutant embryos had a normal stellate morphology and expression of focal adhesion proteins, Src family members, p53 and Pyk2. In contrast, in FAK ∆/∆ fibroblasts and endothelial cells spreading and lamellipodia formation were altered with an increased size and number of focal adhesions, enriched in FAK∆. FAK mutation also decreased fibroblasts proliferation. These results show that the physiological functions of FAK in vivo are achieved through both autophosphorylationindependent and autophosphorylationdependent mechanisms.
Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase critical for processes ranging from embryo development (1) to cancer invasiveness and metastasis (2) . FAK activation following integrin engagement or stimulation of a variety of transmembrane receptors, triggers its phosphorylation on tyrosine and the formation of multimolecular signaling complexes (3) . FAK is enriched in focal adhesions, controlling their turnover and consequently adhesion-related processes such as spreading, migration, survival and proliferation (1) . The important physiological role of FAK is demonstrated by the lethality of its null mutation at embryonic day (E) 8.5 (4, 5) . Further studies using conditional deletion showed that FAK regulates the development of the nervous system (6-9), morphogenesis of the vascular network (5, 10, 11) , and cardiac development (12) (13) (14) (15) . These reports clearly established that FAK is necessary for essential processes in vivo. In vitro studies have shown that, following its recruitment to focal adhesions, FAK autophosphorylation on Tyr-397 creates a highaffinity binding site for multiple signaling proteins including the Src family kinases (SFKs) (3) . Following their binding to phospho-Tyr-397 and activation, SFKs phosphorylate other FAK residues inducing its complete activation, its interaction with other signaling proteins and the stimulation of downstream signalling cascades (16) . The FAK-SFK complexes also regulate cytoskeleton rearrangement and downstream signaling pathways by phosphorylating partner proteins such as p130Cas and paxillin (17, 18) . Thus FAK autophosphorylation on Tyr-397 appears to be critical for both FAK activation and scaffolding function in vitro, triggering the assembly of multimolecular complexes responsible for its cellular effects. Interestingly recent results showed that pharmacological inhibition of FAK activity and autophosphorylation did not block tumor cells proliferation and apoptosis in vitro (19) , suggesting that FAK may also have autophosphorylation-independent functions (20) . Therefore it is particularly important to determine the role of Tyr-397 in FAK functions in vivo. Here we addressed this question using a mutant mouse deleted of FAK exon 15, which encodes 19 amino acids including Tyr-397 (21) . Our results show that the requirement for FAK autophosphorylation varies during development and demonstrate that the physiological functions of FAK in vivo are achieved through both autophosphorylation-independent and autophosphorylation-dependent mechanisms.
EXPERIMENTAL PROCEDURES

Generation of FAK
∆/∆ mice-FAK ∆/∆ mice were generated (see also Supplemental Fig.1 ) in the course of experiments aiming at testing the role of FAK alternatively spliced exons (22) . A DNA fragment containing exons 13-18 from the mouse Ptk2 gene was isolated from a SV129 genomic library (RPCI21MPAC, clone identification RPCIP711H19216Q2; RZPD, Berlin, Germany) and subcloned to construct the targeting vector (Supplemental Fig.1A ). Embryonic stem (ES) cells isolated from male SV129 were electroporated with the targeting vector. Transfected cells were selected with hygromycin, 24 hours later and tested by PCR and Southern blotting (Supplemental Fig. 1A and  B) . For the present study we selected a clone which exhibited the homologous recombination event and an additional spontaneous deletion of a 307 bp genomic fragment including exon 15 Whole mount staining-Embryos were fixed in 4% paraformaldehyde in PBS. After dehydratation in a series of methanol, they were treated with 1% H 2 O 2 , rehydrated from methanol to PBS, and blocked in 4% (w/v) bovine serum albumin-0.1% (v/v) Triton X-100. They were then incubated with anti-PECAM-1 (1:500) in 4% BSA 0.1%Triton X-100 in PBS at 4°C overnight followed by peroxydaseconjugated secondary antibody. The reaction was developed in 0.03% 3-3'-diaminobenzidine with H 2 O 2 . For the whole-mount skin immunostaining, skins were removed after embryo fixation, permeabilized for 2 hours (0,2% triton X100) and blocked (Roche, ref 11096176001) for 2 hours prior to incubation with antibodies against PECAM-1 and biotinylated TuJI (1:200 dilution) in 0.1% triton + 1% BSA+ 1% Goat serum overnight at 4°C. After washes for 4 hours, skins were incubated with secondary antibody (AlexaFluor 555 goat anti-rat) and monoclonal anti smooth muscle α-actin-FITC in blocking solution for 2 hours. Acquisitions were performed with a confocal microscope (Leica, SP5, 10x magnification). Tissue extraction and preparation for immunoblotting-Tissues and organs from embryos or adult mice were frozen immediately after dissection and sonicated later in 100°C, 1% (w/v) SDS (1%) containing NaVO 4 (1 mM), placed in a 100°C heating block for 3 min and processed as described in the immunoblotting section. Cell culture-COS7 cells were grown and transfected with Lipofectamin 2000 (Invitrogen) as previously described (23) . For the primary fibroblasts, four FAK +/+ and 3 FAK ∆/∆ independent mouse embryonic fibroblasts (MEF) populations were prepared from 7 littermates E12.5 embryos of 2 different litters obtained from heterozygous crossings and cultured as described (24) . All experiments were performed between passage 1 and 3. The 7 MEF populations were tested separately in each experiment. Primary endothelial cells (EC) were isolated from FAK +/+ and FAK ∆/∆ E12.5 and E13.5 embryos using magnetic beads (Dynabead M-450; Dynal Corp.) and rat anti-mouse PECAM-1 (CD31) (5) . For the fibronectin replating experiments, MEF or EC were prepared as described (25) before being plated on tissue culture dishes or glass coverslips precoated with polylysine (50 µg/ml) or fibronectin (10 µg/ml) and processed for immunoblotting or immunofluorescence at the indicated times. Immunoblotting-After the appropriate treatment, cells were rinsed, frozen on dry ice, lysed with boiling SDS (1%) containing NaVO 4 (1 mM), sonicated and boiled for 3 min. Protein concentration was determined with the BCA assay (Pierce) and 50 to 100 µg of protein were analyzed by SDS-PAGE. Quantification of immunoblots was performed with Odyssey Li-Cor. Data were normalized to the mean value of untreated controls in the same autoradiograms. Immunofluorescence-Cells were fixed for 15 minutes in 4% (w/v) PFA and permeabilized with TritonX100 0.05% for 5 min. After blocking and incubation with primary antibody overnight, cells were incubated with Alexa-488-or Cy3-coupled secondary antibodies or rhodamin-conjugated phalloidin (1/400) for 1 hour and mounted in Vectashield with DAPI. Acquisition of the images was performed on a Leica DM600B equipped with a numerical camera CCD Micromax (Princeton Instrument) at 20x (N.A. 0.7, PL APO) or 40x (N.A. 1.25, oil, PL APO) using Metamorph software. In experiments with EC, only cells positive for CD31 or CD102 were selected for analysis of immunofluorescence with antibodies recognizing other proteins. Proliferation studies-MEFs were plated separately in triplicate at 7500 cells/well in 24-well plates. The growing medium was changed every other day and cells were fixed everyday with cold methanol and kept at -20°C until the end of the experiment. At that time cells were stained with crystal violet staining and solubilized (24) and cell number was estimated with a spectrophotometer at 590 nm. Data points were the average of triplicates. (21) (Fig. 1A) . FAK∆ was expressed at the same levels as normal FAK encoded by the wild type allele (Supplemental Fig.  1C ). As expected, FAK∆ was not detected by PTyr-397-specific antibodies in transfection experiments. Using a transphosphorylation assay in COS7 cells (23), we found that the basal kinase activity of FAK∆, was moderately increased (Supplemental Fig. 2 (Fig. 1B) . Thus, FAK requirement for normal development is independent of its autophosphorylation until E13.5. Moreover, we observed rare (0.25%) verified FAK ∆/∆ mice, which survived to adulthood and were fertile ( Table  1 and Supplemental Fig. 4 ) whereas no FAK-null adult mice have been reported (4, 5, 26 (17, 18) , we also monitored their expression. We found in E14.5 mutant embryos, a moderate increase in the expression of paxillin and p130Cas, as well as cortactin ( Fig. 2A) (Fig. 2B) . Only a moderate increase (<2-fold) in the level of Pyk2 was observed in these cells compared to FAK +/+ MEFs (Fig. 2B) . This result contrasted with the strong overexpression of Pyk2 that we observed in FAK -/-fibroblasts (~10 fold, data not shown) and that had also been previously reported (25, 28, 29) . The levels of vinculin, p130Cas, paxillin, cortactin, Fyn and Src, were not changed by the fak ∆/∆ mutation in MEFs (Fig. 2B) (Fig. 3A and Fig. 3B ). In contrast, the FN-induced phosphorylation of these residues was lost in FAK ∆/∆ MEFs (Fig. 3A and Fig. 3B ), although SFKs were similarly activated in wild type and mutant MEFs (data not shown). These results show that autophosphorylation on Tyr-397 is critical for SFKdependent tyrosine phosphorylation of FAK and confirm that the moderate increase of FAK∆ basal kinase activity (Supplemental Fig. 2 ) has no effect on FAK activation and Src-mediated signaling. We also examined p130Cas and paxillin, whose phosphorylation by the FAK-SFK complex is important for cytoskeleton rearrangement and activation of downstream signaling pathways (17) . The phosphorylation of both proteins was stimulated by FN in FAK +/+ but not in FAK ∆/∆ MEFs (Fig. 3C, D) despite a similar interaction of endogenous FAK and FAK∆ with both p130Cas and paxillin in these cells or after overexpression in COS7 (data not shown). In contrast, the phosphorylation of cortactin, which is known to be catalyzed by SFKs independently of FAK (27), was unaffected in FAK ∆/∆ cells (Fig. 3E ). Previous studies proposed that the phosphorylation of p130Cas and paxillin by Src may be achieved through both FAK-dependent and independent mechanisms (29, 31 (Fig. 4A) . Instead, FAK ∆/∆ cells exhibited multiple thinner membrane protrusions containing dense actin fibers (Fig. 4A) . These narrow actin-rich membrane extensions of FAK ∆/∆ MEFs remained prominent after 1 hour on FN and were identified as abnormal lamellipodia since cortactin, which normally localizes at the edges of protruding lamellipodia, was localized at their tips (Fig. 4B) . A similar phenotype was reported in several cell types lacking FAK expression (10, 32, 33 3A and B ) may contribute to the increased number and size, of focal adhesions, and their enrichment in FAK∆ protein (Fig. 4A-F 
RESULTS AND DISCUSSION
Generation of fak∆ mice expressing an active but autophosphorylation-deficient mutant form of FAK-
Proliferation of FAK ∆/∆ fibroblasts is decreased-
FAK is implicated in the control of cell growth (28, 34) , although its importance depends on cell types (19, 20, 35) . We compared the proliferation of and they reached a lower saturation density (Fig.  5A ). These results demonstrate that FAK autophosphorylation on Tyr-397 is required for normal proliferation of MEFs (Fig. 5A) . However, growth of FAK ∆/∆ MEFs was mostly restored at a higher serum concentration (Fig. 5B) , suggesting that the proliferative defect due to the lack of FAK autophosphorylation could be compensated by increased proliferative signals. FAK -/-embryonic mesodermal cells in vivo or FAK -/-fibroblasts in vitro also exhibited a proliferation defect attributed to an up-regulation of p53 (20, 36) . This upregulation may account for the use of a p53 -/-background to establish FAK -/-fibroblasts (4). Indeed FAK FERM domain binds to and causes the degradation of p53, independently of its autophosphorylation and kinase activity (20, 37 ). However we showed that p53 was not increased in FAK ∆/∆ MEFs (Fig. 2C) . Thus, the lack of FAK autophosphorylation is likely to inhibit cell proliferation by an alternative pathway. The contrast between the phenotype of FAK -/-and FAK ∆/∆ embryos provides strong evidence for autophosphorylation-independent functions of FAK in vivo. Such functions have been suggested in cultured cells, in addition to the aforementioned regulation of p53 expression. For example, pharmacological inhibition of FAK did not block proliferation of tumor cells and did not block their apoptosis in vitro (19) . Durotaxis, the ability of cells, cultured on a substrate of graded stiffness, to move from softer to stiffer regions, was abolished in FAK -/-cells and rescued by FAKY397F, which did not rescue the migration speed (38) . Furthermore, abnormal axonal branching in hippocampal FAK -/-neurons was partially rescued by the expression of FAKY397F (7) . Although very few bona fide substrates of FAK have been characterized in intact cells (1), the respective role of FAK catalytic activity and scaffolding properties will have to be determined in these autophosphorylation-independent functions. Auto-phosphorylation-independent function of FAK is also supported by the observation that although Tyr-397 is highly conserved in most metazoans, it is not found in C. elegans (21) .
In conclusion, the study of FAK ∆/∆ mice provides important information about the role of FAK autophosphorylation on Tyr-397 in vivo. FAK autophosphorylation is not required for development before E13.5 but becomes necessary past that stage. The autophosphorylation of FAK on Tyr-397 is not necessary for general cell morphology in standard culture conditions or to repress p53 and Pyk2 expression. In contrast, it plays an important role in focal adhesion turnover, lamellipodia formation, cell spreading and proliferation. Thus, our results demonstrate that the physiological functions of FAK in vivo are achieved through both autophosphorylation-independent and autophosphorylation-dependent mechanisms and that the requirements for these mechanisms vary during development. They underline that identification of the mechanisms by which FAK regulates different cellular functions will be important to improve the design of appropriate therapeutic tools. grown in the indicated serum concentrations and counted by crystal violet staining at D=0 or after 7 days in culture (D=7). Data (means ± SEM n= 3-4) were analyzed using two-way ANOVA. Bonferroni post-test: ** p < 0.01, *** p < 0.001. allele and a 1 kb fragment from the wild type allele respectively. Fragments were separated on 0.8% agarose gels. The three products are seen in a heterozygous FAK +/∆ mouse, whereas the band corresponding to the wild type allele is absent in an adult homozygous mutant mouse (FAK ∆/∆ ).
